跳至主要内容
临床试验/NL-OMON38722
NL-OMON38722已完成不适用

The effect of hesperidin administration on endothelial function and gut barrier function - The effect of hesperidin on endothelial function

niversiteit Maastricht0 个研究点目标入组 68 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
68

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Men/women, BMI 25-35 kg/m2, healthy human beings, age 18-70 years, fasting glucose <7.0 mmol/L, Hba1c between 4.4-6.2%

排除标准

  • Type 2 diabetes mellitus; gastroenterological diseases or abdominal surgery; cardiovascular diseases; cancer; liver or kidney malfunction; disease with life expectancy shorter than 5 years; self admitted HIV-positive status; abuse of products such as alcohol (> 20 alcoholic consumptions per week) or drugs; smoking; plans to lose weight or following a hypocaloric diet; weight gain or loss > 3 kg in previous 3 months; use of medication interfering with endpoints (intake of antihypertensive medication, statins, corticosteroids, NSAIDs, ciclosporin A, rifampicin is strictly forbidden); use of antioxidants, minerals and vitamin supplements available in pharmacies, drugstores, food markets, or in alternative medicine; hormone replacement therapy, use of antibiotics in the 90 days prior to the start of study; known pregnancy, lactatation; history of side effects towards intake of flavonoids or citrus fruits; administration of investigational drugs or participating in any scientific intervention study which may interfere with this study ( to be decided by principal investigator) in the 180 days prior to the study; blood donation within 3 months before study period; Failure to comply prohibited intake of hesperidin containing food products during study period and prohibited intake of food products that are able to influence FMD measurements one day prior to test days.

研究者

相似试验